Mary B. Daly, M.D., Ph.D., Named Senior Vice President of Population Science Division at Fox Chase Cancer Center
PHILADELPHIA (January 6, 2006) - Fox Chase Cancer Center has announced the appointment of Mary B. Daly, MD, PhD, as senior vice president of the population science division, effective Jan. 1. Daly also becomes the first to hold the new Timothy R. Talbot Jr. Chair in Cancer Research, named for the first president of Fox Chase.
Daly succeeds Paul F. Engstrom, MD, who has assumed responsibilities as senior vice president for extramural research programs. Daly oversees Fox Chase programs in behavioral research, human genetics, epidemiologic research and cancer prevention research.
Daly is an internationally recognized leader in cancer control, having served as director of the cancer prevention and control program at Fox Chase Cancer Center since 1999. A medical oncologist specializing in epidemiology, breast and ovarian cancers, Daly is renowned for her work in the development of evidence-based interventions for cancer risk education, risk counseling, risk communication and behavior modification.
Daly is founder and director of the Margaret Dyson Family Risk Assessment Program at Fox Chase. This program-one of the first of its kind and the only one in the region when it opened in 1991-is a prevention and early-detection program for women with a hereditary or genetic risk of breast or ovarian cancer.
"Mary is tremendously respected in the field of preventative oncology for her insight and leadership and her Fox Chase colleagues revere her for her unwavering dedication to patients," said Robert C. Young, M.D., president of Fox Chase Cancer Center. "Mary is an invaluable asset to Fox Chase and her contributions as a senior leader will be significant in guiding this world-class research institution in the coming years."
Daly noted, "Dr. Tim Talbot was a true visionary and a respected leader. I am honored to hold his chair as senior vice president. As the leader of the population science division, I hope to build on the foundation created by Dr. Paul Engstrom and continue to forge a path to cancer prevention."
Engstrom will oversee Fox Chase extramural research programs such as those involving the Oncology Physician Network, the National Comprehensive Cancer Network, the Cancer Information Service partnership program and other research activities. He will remain as medical director of the Fox Chase Network, a select group of 27 Pennsylvania and New Jersey community hospitals affiliated with Fox Chase, and as the medical director for the American-Russian Cancer Alliance.
Daly joined Fox Chase in 1989. She has served on several national and international scientific committees, including the Board of Scientific Advisors to the National Cancer Institute (NCI), Board of Scientific Counselors for the NCI's Cancer Prevention and Control Division, the Human Genome Cancer Studies Consortium and the Observational Study Monitoring Board for the Women's Health Initiative. She is past-president of the American Society of Preventive Oncology.
Daly is currently the principal investigator for two peer-reviewed grants from the NCI as well as grants from the Pennsylvania Department of Health. She is co-principal investigator for Fox Chase's U01 grant for the Early Detection Research Network.
Daly is board-certified in internal medicine and medical oncology by the American Board of Internal Medicine. She is a fellow of the American College of Physicians and a member of the American Association for Cancer Research, American Society of Clinical Oncology, American College of Epidemiology, American Association of Cancer Education and several other professional organizations.
Daly has received numerous awards for her exemplary contributions to the science of cancer control, including the American Cancer Society Cancer Control Award in 1996 and 2004 and the John Peter Minton, M.D., Ph.D., Memorial Lectureship at Ohio State's James Cancer Center.
Born in Bridgeport, Conn., Daly earned her B.A. in biology at New York's College of New Rochelle in 1965. She received her M.S. in public health, Ph.D. in epidemiology and M.D. from University of North Carolina at Chapel Hill. She received all of her internal medicine and medical oncology training at the University of Texas Health Science Center in San Antonio.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.